Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine (sold under the ...
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...
The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due ...
Rhythm Technologies (Nasdaq:IRTC) announced today that it received FDA 510(k) clearance related to design changes made to its ...
Michelle Tarver will be the new leader of the medical devices center at the Food and Drug Administration, according to an ...
Michelle Tarver will officially replace longtime CDRH leader Jeff Shuren, who stepped down from the role earlier this year.
The Food and Drug Administration, in collaboration with the U.S. Customs and Border Protection (CBP), seized about three ...